Press Enter to search · ESC to close

US Stocks

Johnson & Johnson to acquire Ollin Biosciences for up to $3.33B

Johnson & Johnson will acquire biopharmaceutical company Ollin Biosciences for up to $3.33 billion. The deal value was reported by Bloomberg. No further terms of the transaction were disclosed.

Original source

Share

Related News

TREE NEWS share card
Long-press image above → Save to Photos / Share
Pitch us Feedback